berzosertib,gemcitabine
merck
['ovarian', 'biomarker', 'gemcitabine', 'berzosertib']
join poster discussion at #asco23 randomized phase 2 study (nci-9944) of gemcitabine w or w/o atr inhibitor berzosertib in platinum-resistant ovarian cancer: final overall survival and biomarker analyses 4:30-6:00pm cdt, this afternoon! more: 
Official Twitter account of NCI's Cancer Therapy Evaluation Program, providing updates to our trials research community. Part of @NIH. Privacy: https://t.co/9Aox3geiD8